Cell Division Protein FtsZ (ftsz) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms a contractile ring structure at the future cell division site. The regulation of the ring assembly controls the timing and the location of cell division. It recruits other cell division proteins to the septum to produce a new cell wall between the dividing cells.
The Cell Division Protein FtsZ (ftsz) – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for FtsZ, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for FtsZ and features dormant and discontinued projects.
Key Therapy Areas in the Cell Division Protein FtsZ (ftsz) Pipeline Drugs Market
In the FtsZ pipeline drugs market the key therapy area is Infectious Disease.
Key MoA in the FtsZ Pipeline Drugs Market
In the FtsZ Pipeline Drugs Market the key mechanism of action is Cell Division Protein FtsZ Inhibitor.
Cell Division Protein FtsZ (ftsz) Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the FtsZ pipeline drugs market are intravenous, and oral.
Key Molecule Types in the FtsZ Pipeline Drugs Market
The key molecule types in the FtsZ pipeline drugs market are Small Molecule, and Antisense RNAi Oligonucleotide. Small Molecule has the maximum number of products.
FtsZ Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Cell Division Protein FtsZ (ftsz) Pipeline Drugs Market
The major companies in the FtsZ pipeline drugs market are Pedanius Therapeutics Ltd, and TAXIS Pharmaceuticals Inc.
FtsZ Pipeline Drugs Market Overview
Key Therapy Areas | Infectious Disease |
Key Mechanisms of action | Cell Division Protein FtsZ Inhibitor |
Key Routes of Administration | Intravenous, and Oral |
Key molecule types | Small Molecule, and Antisense RNAi Oligonucleotide |
Major companies | Pedanius Therapeutics Ltd, and TAXIS Pharmaceuticals Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of FtsZ
- The pipeline guide reviews pipeline therapeutics for FtsZ by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in FtsZ therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates FtsZ therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for FtsZ
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective countercstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for FtsZ
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding FtsZ pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
TAXIS Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the FtsZ pipeline drugs market?
In the FtsZ pipeline drugs market the key therapy area is Infectious Disease.
-
What are the key mechanisms of action in the FtsZ pipeline drugs market?
In the FtsZ pipeline drugs market the key mechanism of action is Cell Division Protein FtsZ Inhibitor.
-
What are the key routes of administration in the FtsZ pipeline drugs market?
The key routes of administration in the FtsZ pipeline drugs market are Intravenous, and Oral.
-
What are the key molecule types in the FtsZ pipeline drugs market?
The key molecule types in the FtsZ pipeline drugs market are Small Molecule, and Antisense RNAi Oligonucleotide.
-
What are the major companies in the FtsZ pipeline drugs market?
In the FtsZ pipeline drugs market the major companies are Pedanius Therapeutics Ltd, and TAXIS Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.